AR134161A1 - HETEROARYL COMPOUNDS FOR PAIN TREATMENT - Google Patents
HETEROARYL COMPOUNDS FOR PAIN TREATMENTInfo
- Publication number
- AR134161A1 AR134161A1 ARP240102846A ARP240102846A AR134161A1 AR 134161 A1 AR134161 A1 AR 134161A1 AR P240102846 A ARP240102846 A AR P240102846A AR P240102846 A ARP240102846 A AR P240102846A AR 134161 A1 AR134161 A1 AR 134161A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- pharmaceutically acceptable
- pain treatment
- heteroaryl compounds
- acceptable salt
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de fórmula (I-A). Un compuesto seleccionado de la Tabla A, opcionalmente en donde el compuesto se selecciona de la Tabla B, o una sal farmacéuticamente aceptable de este. Un compuesto seleccionado de la Tabla C, o una sal farmacéuticamente aceptable de este. Un compuesto seleccionado de la Tabla D, o una sal farmacéuticamente aceptable de este. Un compuesto seleccionado de la Tabla E, o una sal farmacéuticamente aceptable de este. Una composición farmacéutica que comprende el compuesto de cualquiera de las reivindicaciones 1 a 29, o una sal farmacéuticamente aceptable de esta, o el compuesto de la reivindicación 30 y uno o más portadores o vehículos farmacéuticamente aceptables.A compound of formula (I-A). A compound selected from Table A, optionally wherein the compound is selected from Table B, or a pharmaceutically acceptable salt thereof. A compound selected from Table C, or a pharmaceutically acceptable salt thereof. A compound selected from Table D, or a pharmaceutically acceptable salt thereof. A compound selected from Table E, or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprising the compound of any one of claims 1 to 29, or a pharmaceutically acceptable salt thereof, or the compound of claim 30 and one or more pharmaceutically acceptable carriers or vehicles.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063644192P | 2020-05-08 | 2020-05-08 | |
| US202063592698P | 2020-10-24 | 2020-10-24 | |
| US202363592362P | 2023-10-23 | 2023-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR134161A1 true AR134161A1 (en) | 2025-12-10 |
Family
ID=98218434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240102846A AR134161A1 (en) | 2020-05-08 | 2024-10-22 | HETEROARYL COMPOUNDS FOR PAIN TREATMENT |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR134161A1 (en) |
-
2024
- 2024-10-22 AR ARP240102846A patent/AR134161A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR122351A1 (en) | METHYLQUINAZOLINONE DERIVATIVES AS BRAF INHIBITORS | |
| AR132338A1 (en) | RAS INHIBITORS | |
| AR128931A1 (en) | COMPLEMENT B FACTOR INHIBITORS AND USES THEREOF | |
| AR126251A1 (en) | CDK2 INHIBITORS | |
| AR132007A1 (en) | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | |
| PE20251667A1 (en) | Cyclic thiazolyl urea compounds for the treatment of HSV | |
| AR131639A1 (en) | KIF18A INHIBITORS AND THEIR USES | |
| AR128932A1 (en) | BCL-XL INHIBITORS | |
| AR131906A1 (en) | THERAPEUTIC COMPOUNDS | |
| MX2023001725A (en) | SPIROPIPERIDINYL DERIVATIVES SUBSTITUTED WITH HETEROARYL AND PHARMACEUTICAL USES THEREOF. | |
| AR130303A1 (en) | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | |
| AR127496A1 (en) | CD73 COMPOUNDS | |
| AR134161A1 (en) | HETEROARYL COMPOUNDS FOR PAIN TREATMENT | |
| AR132764A1 (en) | TYK2 INHIBITORS AND THEIR USES | |
| AR128693A1 (en) | ANTIVIRAL COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF | |
| AR129212A1 (en) | PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS | |
| AR132973A1 (en) | COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| AR132987A1 (en) | COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| AR125934A1 (en) | MACROCYCLIC COMPOUNDS TO TREAT DISEASES | |
| AR124982A1 (en) | MACROCYCLES AND THEIR USES | |
| AR128896A1 (en) | IKZF2 DEGRADERS AND USES OF THESE | |
| AR132531A1 (en) | HETEROCYCLIC COMPOUNDS AS PARP1 INHIBITORS | |
| AR134110A1 (en) | RAS INHIBITORS | |
| AR131099A1 (en) | HETEROARYL FLUOROALKENES AS DGK INHIBITORS | |
| AR116080A1 (en) | DERIVATIVES OF 1-IMIDAZOTIADIAZOL-2H-PIRROL-5-ONA |